Krzysztof Sładek Selected Research

Krzysztof Sładek Research Topics

Disease

10	Asthma (Bronchial Asthma) 01/2023 - 06/2003
7	COVID-19 01/2023 - 01/2021
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2010
4	Idiopathic Pulmonary Fibrosis 07/2023 - 05/2020
3	Inflammation (Inflammations) 01/2022 - 06/2003
3	Airway Remodeling 01/2022 - 06/2016
3	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2010 - 01/2006
2	Chronic Renal Insufficiency 03/2024 - 10/2022
2	Disease Progression 07/2023 - 05/2020
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2021
2	Thrombophilia 01/2023 - 01/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2010
2	Infections 01/2021 - 03/2016
2	Tuberculosis (Tuberculoses) 01/2019 - 03/2016
2	Hypersensitivity (Allergy) 01/2016 - 01/2009
2	Aspirin-Induced Asthma 01/2016 - 01/2016
2	Sarcoidosis (Schaumann Disease) 07/2007 - 01/2006
2	Malignant Pleural Effusion 03/2005 - 06/2003
1	Vomiting 07/2023
1	Nausea 07/2023
1	Diarrhea 07/2023
1	Weight Loss (Weight Reduction) 07/2023
1	Fatigue 07/2023
1	Critical Illness (Critically Ill) 01/2023
1	Hemorrhage 01/2022
1	Obstructive Sleep Apnea 01/2021
1	Airway Obstruction (Choking) 01/2021
1	Apnea 01/2021
1	Eosinophilia 01/2021
1	Insect Bites and Stings (Insect Bite) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Hypoventilation 10/2019
1	Chronic Bronchitis 01/2019
1	Emphysema 01/2019
1	Latent Tuberculosis 03/2016
1	Pulmonary Vein Stenosis 01/2016
1	Atrial Fibrillation 01/2016
1	Hemoptysis 01/2016

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2013
4	Omalizumab (Xolair)FDA Link 01/2022 - 10/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2018
2	nintedanibIBA 07/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2020
2	pirfenidoneIBA 01/2022 - 05/2020
2	EicosanoidsIBA 01/2021 - 01/2012
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 03/2016 - 07/2007
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016 - 01/2009
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2016
1	ProcalcitoninIBA 03/2024
1	Transaminases (Aminotransferases)IBA 07/2023
1	Anticardiolipin AntibodiesIBA 01/2023
1	factor V LeidenIBA 01/2023
1	Prothrombin (Factor II)IBA 01/2023
1	AntigensIBA 01/2023
1	Antiphospholipid AntibodiesIBA 01/2023
1	Protein CIBA 01/2023
1	Protein SIBA 01/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Hemostatics (Antihemorrhagics)IBA 01/2023
1	Thrombin FDA Link 01/2023
1	AntithrombinsIBA 01/2023
1	Carbon MonoxideIBA 01/2022
1	Transfer Factor (Factor, Transfer)IBA 01/2022
1	fibrin fragment D (D-dimer)IBA 01/2021
1	11-dehydro-thromboxane B2IBA 01/2021
1	AcidsIBA 01/2021
1	AerosolsIBA 01/2021
1	Cardiovascular AgentsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	LipidsIBA 01/2021
1	Prostaglandin D2IBA 01/2021
1	5-oxo-eicosatetraenoic acidIBA 01/2021
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 10/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	ChemokinesIBA 01/2019
1	Metalloproteases (Metalloproteinases)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Interleukin-33IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2018
1	Pancreatic Elastase (Elastase)IBA 06/2016
1	GoldIBA 03/2016
1	Tuberculin (PPD)IBA 03/2016
1	Dinoprostone (PGE2)FDA Link 01/2016

Therapy/Procedure

9	Therapeutics 07/2023 - 12/2018
2	Bronchial Thermoplasty 01/2023 - 10/2010
2	Pleurodesis 03/2005 - 06/2003
1	Length of Stay 02/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Continuous Positive Airway Pressure 01/2021
1	Bariatric Surgery 01/2021
1	Lung Transplantation 05/2020
1	Contraindications 10/2019
1	Aftercare (After-Treatment) 12/2018
1	Home Nursing (Nursing, Home) 03/2016
1	Catheter Ablation 01/2016